{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-016480","form_type":"8-K","ticker":"HYPR","cik":"0001833769","company_name":"Hyperfine, Inc.","filed_at":"2022-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.331632+00:00","generated_at":"2026-06-24T01:33:56.894586+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Hyperfine Q2 revenue up 328% YoY to $1.5M; net loss $23.2M ($0.33/shr)","bullets":["Revenue $1.533M (Q2 2022) vs $0.358M (Q2 2021); gross margin negative at ($0.165M).","Net loss $23.159M, $0.33 loss per share vs $8.80 loss per share in prior year.","Placed 9 commercial Swoop systems in Q2; total 20 YTD and 47 launch-to-date; installed base 92.","FY 2022 guidance: revenue $7-8M and 35-45 commercial unit installations expected.","Received FDA clearances for new deep-learning imaging sequences; partnered with Viz.ai for neuro ICU."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-016480","json":"https://secwatch.observer/filing/0000950170-22-016480.json","markdown":"https://secwatch.observer/filing/0000950170-22-016480.md","text":"https://secwatch.observer/filing/0000950170-22-016480.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833769/000095017022016480/0000950170-22-016480-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833769/000095017022016480/hypr-20220810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T01:33:56.894586+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}